Actively Recruiting
Monoferric for Prenatal Iron Deficiency
Led by Oregon Health and Science University · Updated on 2024-09-19
80
Participants Needed
1
Research Sites
245 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
CONDITIONS
Official Title
Monoferric for Prenatal Iron Deficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female participants 18 years or older
- Currently between 14 to 42 weeks of pregnancy
- Diagnosed with iron deficiency anemia with hemoglobin ≤10.5 g/dL (second trimester) or ≤11 g/dL (third trimester) and ferritin <50 µg/L
- Experience intolerance to oral iron or are more than 28 weeks pregnant
- Considered appropriate for intravenous iron treatment by their healthcare provider
- Willing to participate in the study
You will not qualify if you...
- Presence of known infectious, inflammatory, or malignant conditions that could affect iron treatment or study results
- History of intolerance or allergic reaction to intravenous iron therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oregon Health & Science Univerity
Portland, Oregon, United States, 97239
Actively Recruiting
Research Team
W
Women's Health Research Unit Research Unit Department of OB/Gyn
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here